IL191922A0 - Pharmaceutical formulations of oxcarbazepine and methods for its preparation - Google Patents

Pharmaceutical formulations of oxcarbazepine and methods for its preparation

Info

Publication number
IL191922A0
IL191922A0 IL191922A IL19192208A IL191922A0 IL 191922 A0 IL191922 A0 IL 191922A0 IL 191922 A IL191922 A IL 191922A IL 19192208 A IL19192208 A IL 19192208A IL 191922 A0 IL191922 A0 IL 191922A0
Authority
IL
Israel
Prior art keywords
oxcarbazepine
preparation
methods
pharmaceutical formulations
formulations
Prior art date
Application number
IL191922A
Original Assignee
Teva Pharma
Kolatkar Gershon
Blau Sigal
Zalit Llan
Azaria Carolina
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/350,606 external-priority patent/US20070178164A1/en
Application filed by Teva Pharma, Kolatkar Gershon, Blau Sigal, Zalit Llan, Azaria Carolina filed Critical Teva Pharma
Publication of IL191922A0 publication Critical patent/IL191922A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IL191922A 2006-01-31 2008-06-03 Pharmaceutical formulations of oxcarbazepine and methods for its preparation IL191922A0 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US76413406P 2006-01-31 2006-01-31
US11/350,606 US20070178164A1 (en) 2006-01-31 2006-02-08 Pharmaceutical formulations of oxcarbazepine and methods for its preparation
US86033306P 2006-11-20 2006-11-20
US89736107P 2007-01-24 2007-01-24
PCT/US2007/002882 WO2007089926A2 (en) 2006-01-31 2007-01-31 Oxcarbazepine pharmaceutical formulation and its method of preparation, wherein oxcarbazepine has a broad and multi-modal particle size distribution

Publications (1)

Publication Number Publication Date
IL191922A0 true IL191922A0 (en) 2009-08-03

Family

ID=38328068

Family Applications (1)

Application Number Title Priority Date Filing Date
IL191922A IL191922A0 (en) 2006-01-31 2008-06-03 Pharmaceutical formulations of oxcarbazepine and methods for its preparation

Country Status (6)

Country Link
EP (1) EP2029118A2 (en)
JP (1) JP2008540346A (en)
AU (1) AU2007211210A1 (en)
CA (1) CA2634879A1 (en)
IL (1) IL191922A0 (en)
WO (1) WO2007089926A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1815849A1 (en) * 2006-01-31 2007-08-08 Teva Pharmaceutical Industries Ltd Oxcarbazepine pharmaceutical formulation and its method of preparation, wherein oxcarbazepine has a broad and multi-modal particle size distribution
US8372431B2 (en) 2007-10-26 2013-02-12 Bial-Portela & C.A., S.A. Pharmaceutical composition comprising licarbazepine acetate
EP2968354B1 (en) * 2013-03-15 2019-11-13 Aprecia Pharmaceuticals LLC Rapidly dispersible dosage form of oxcarbazepine
JP6843498B2 (en) * 2015-10-14 2021-03-17 Ｅａファーマ株式会社 Tablets, solid dispersion granules and methods for producing them

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5354563A (en) * 1985-07-15 1994-10-11 Research Development Corp. Of Japan Water dispersion containing ultrafine particles of organic compounds
JP3170069B2 (en) * 1992-10-06 2001-05-28 日水製薬株式会社 Sustained release granules
US5472714A (en) * 1993-09-08 1995-12-05 Ciba-Geigy Corporation Double-layered oxcarbazepine tablets
CO4920215A1 (en) * 1997-02-14 2000-05-29 Novartis Ag OXACARBAZEPINE TABLETS COATED WITH A FILM AND METHOD FOR THE PRODUCTION OF THESE FORMULATIONS
GB9925962D0 (en) * 1999-11-02 1999-12-29 Novartis Ag Organic compounds
MXPA03010549A (en) * 2001-05-18 2004-05-27 Ranbaxy Lab Ltd Oxcarbazepine dosage forms.
MXPA04011801A (en) * 2002-05-31 2005-09-12 Desitin Arzneimittel Gmbh Pharmaceutical composition containing oxcarbazepine and having a controlled active substance release.
GB0221956D0 (en) * 2002-09-20 2002-10-30 Novartis Ag Organic compounds
WO2006046105A1 (en) * 2004-10-25 2006-05-04 Ranbaxy Laboratories Limited Oxcarbazepine dosage forms
WO2007007182A2 (en) * 2005-07-08 2007-01-18 Aurobindo Pharma Limited Solid and liquid dosage forms of an antiepileptic agent
EP1815849A1 (en) * 2006-01-31 2007-08-08 Teva Pharmaceutical Industries Ltd Oxcarbazepine pharmaceutical formulation and its method of preparation, wherein oxcarbazepine has a broad and multi-modal particle size distribution
EP2010499A4 (en) * 2006-04-21 2012-07-18 Alphapharm Pty Ltd Pharmaceutical compositions of oxcarbazepine with a median particle size of 15 to 30 microns

Also Published As

Publication number Publication date
JP2008540346A (en) 2008-11-20
WO2007089926A3 (en) 2008-12-24
AU2007211210A1 (en) 2007-08-09
EP2029118A2 (en) 2009-03-04
WO2007089926A2 (en) 2007-08-09
CA2634879A1 (en) 2007-08-09

Similar Documents

Publication Publication Date Title
IL275854A (en) Pharmaceutical composition and administration thereof
ZA200900345B (en) Preparation of pharmaceutical formulations
IL195491A (en) Pharmaceutical compositions of tmc278 and processes for their preparation
HK1214153A1 (en) Methods and compositions for oral administration of proteins
HK1249031A1 (en) Methods of vaccine administration
IL194546A0 (en) Arylaminopyridine derivatives and pharmaceutical compositions containing them
IL195237A0 (en) Conjugates of aziridinyl-epothilone analogs and pharmaceutical compositions comprising same
IL199853A (en) Substituted derivatives of 5-hydroxy-adamantyl-2-yl and pharmaceutical compositions comprising them
HK1125295A1 (en) Microtablet-based pharmaceutical preparation
IL184735A0 (en) Pharmaceutical formulations and methods of use
PT2413913T (en) Pharmaceutical formulations comprising nitrocatechol derivatives and methods of making the same
ZA201007522B (en) Methods and compositions for oral administration of proteins
IL197877A (en) Uses of aminomethyl-4-imidazole derivatives for the preparation of medicaments and medicaments comprising them
EP1895991A4 (en) Modified release formulations of anti-irritability drugs
IL206594A (en) Azinone-tetrahydropyridoindole derivatives and pharmaceutical compositions comprising thereof
ZA200900423B (en) Methods and medicaments for administration of ibuprofen
IL196228A0 (en) 4-hydroxythiobenzamide derivatives of drugs
IL193211A (en) Indazole-heteroaryl derivatives and pharmaceutical compositions comprising them
HUS2000053I1 (en) Quinolinone derivatives and their pharmaceutical compositions
IL197273A0 (en) Pharmaceutical and sunscreen compositions comprising caspase-14
PL2002828T3 (en) Solid pharmaceutical preparation
ZA200900230B (en) 4-hydroxythiobenzamide derivatives of drugs
EP2322505A4 (en) 1-adamantylazetidin-2-one derivative and pharmaceutical preparation comprising same
IL191922A0 (en) Pharmaceutical formulations of oxcarbazepine and methods for its preparation
EP1855647A4 (en) Delayed release pharmaceutical oral dosage form and method of making same